Patents by Inventor Mark W. Ruddock

Mark W. Ruddock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSIS OF RISK OF UROTHELIAL CANCER
    Publication number: 20180011115
    Abstract: The present invention related to a method for detecting a history of exposure to a chemical(s) comprising measuring the concentration of thrombomodulin in a sample isolated from a subject, and determining whether the concentration of thrombomodulin is altered compared to control reference levels.
    Type: Application
    Filed: January 29, 2016
    Publication date: January 11, 2018
    Inventors: Mark W. Ruddock, Cherith N. Reid, Kate E. Williamson, John Lamont, Peter Fitzgerald
  • Method for detection of, or the risk of, bladder cancer
    Patent number: 9562905
    Abstract: Methods for the detection of, or the risk of, bladder cancer in a patient, comprising assaying for the presence of a combination of at least two biomarkers selected from CEA, VEGF, IL-8, NGAL, NSE, IL-2, EGF, TM, d-Dimer, MMP-9, IL-6, IL-4, MMP-9/NGAL, FAS, CRP, TUP and NMP22 in one or more samples isolated from a patient wherein detecting the presence of a combination of at least two biomarkers in the one or more samples indicates the presence or risk of bladder cancer.
    Type: Grant
    Filed: July 29, 2010
    Date of Patent: February 7, 2017
    Assignee: RADOX LABORATORIES LIMITED
    Inventors: Mark W. Ruddock, Cherith N. Reid, Kathleen Williamson, John V. Lamont, Stephen P. Fitzgerald
  • METHODS OF DETECING BLADDER CANCER
    Publication number: 20140072987
    Abstract: The disclosure relates to methods of detecting bladder cancer including assaying a patient sample for the levels of certain combinations of biomarkers. The disclosure also relates to methods for determining the efficacy of a drug for the treatment of bladder cancer.
    Type: Application
    Filed: September 12, 2013
    Publication date: March 13, 2014
    Applicant: RANDOX LABORATORIES LTD.
    Inventors: Mark W. Ruddock, Cherith N. Reid, Kathleen Williamson, John V. Lamont, Stephen P. Fitzgerald
  • METHOD FOR DETECTION OF, OR THE RISK OF, BLADDER CANCER
    Publication number: 20120135886
    Abstract: The present invention provides a method for the detection of or the risk of bladder cancer in a patient, comprising the step of detecting the presence of a combination of at least two biomarkers selected from CEA, VEGF, IL-8, NGAL, NSE, IL-2, EGF, TM, d-Dimer, MMP-9, IL-6, IL-4, MMP-9/NGAL, FAS, CRP, TUP and NMP22 in one or more samples isolated from a patient wherein the presence of a combination of at least two biomarkers in the one or more samples indicates the presence or risk of bladder cancer.
    Type: Application
    Filed: July 29, 2010
    Publication date: May 31, 2012
    Inventors: Mark W. Ruddock, Cherith N. Reid, Kathleen Williamson, John V. Lamont, Stephen P. Fitzgerald